Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Epoxide hydrolase inhibitor
BML-EI392-0050 50 mg 338.00 USD
Do you need bulk/larger quantities?
Novel inhibitor of soluble epoxide hydrolase (IC50=18nM and 69nM for the mouse and human enzymes respectively). Produces a hypotensive effect in angiotensin-infused rats and prevents and reverses cardiac hypertrophy in mouse models of cardiac hypertrophy.

Product Details

Alternative Name:12-(3-Adamantan-1-yl-ureido)-dodecanoic acid
Purity:≥98% (TLC)
Appearance:White solid.
Solubility:Soluble in DMSO (10mg/ml) or 100% ethanol (4mg/ml).
Shipping:Ambient Temperature
Long Term Storage:-20°C
Use/Stability:Store solutions at -20°C for up to 3 months.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors: D. Xu, et al.; PNAS U.S.A. 103, 18733 (2006), Abstract;
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension: J.D. Imig, et al.; Hypertension 46, 975 (2005), Abstract;
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases: C. Morisseau, et al.; Biochem. Pharmacol. 63, 1599 (2002), Abstract;

Related Literature

Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

All new literature pieces